EIKO LIFESCIENCES LIMITED
Latest filings
- Promoter group Lenus Finvest acquires 1.5 lakh shares via warrant conversion · Ownership Changes
- Eiko LifeSciences allots shares on warrant conversion to promoter · Fund Raising
- No dematerialisation requests received in H1 FY27 · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates two business segments: Speciality Chemicals & Pharma Intermediates and Logistics Services. In FY26 consolidated revenue was Rs 52.71 crore with a 15.96% EBITDA margin and net profit of Rs 5.32 crore. In the quarter ended 31 March 2026 the specialty chemicals segment booked Rs 16.88 crore of revenue and Rs 1.25 crore of EBIT, while Logistics Services contributed Rs 1.46 crore of revenue and Rs 0.29 crore of EBIT. The group consolidates subsidiaries Eiko Scientific Solutions LLP and Eikovivify Logistics and associate Reflux Pharmaceuticals, and in January 2026 took a 31.68% stake in SSM Formulations Private Limited, a WHO-GMP pharmaceutical formulations manufacturer based in Hinganghat Wardha. Raw materials are by far the largest cost at 78.3% of revenue, with capex at 0.0% of revenue in FY26.
Scorecard
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from EIKO LIFESCIENCES LIMITED's filed financials and exchange disclosures
What does EIKO LIFESCIENCES LIMITED do?
EIKO LIFESCIENCES LIMITED is a Chemicals & Petrochemicals company listed on BSE.
Is EIKO LIFESCIENCES LIMITED profitable?
Yes. Over the trailing twelve months EIKO LIFESCIENCES LIMITED reported a net profit of ₹5.32 Cr on revenue of ₹53 Cr.
Does EIKO LIFESCIENCES LIMITED pay a dividend?
Not in the latest reported year — EIKO LIFESCIENCES LIMITED's dividend payout for FY26 was nil.
Is EIKO LIFESCIENCES LIMITED debt-free?
On a net basis, yes. It reported borrowings of ₹4.73 Cr on its 31 Mar 2026 balance sheet, but holds ₹8.88 Cr more cash than debt.
Is EIKO LIFESCIENCES LIMITED expensive compared with its peers?
On trailing P/E, EIKO LIFESCIENCES LIMITED ranks 29 of 99 in Specialty Chemicals — cheaper than 71% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.
How much does the EIKO LIFESCIENCES LIMITED share price move in a day?
On a typical session EIKO LIFESCIENCES LIMITED moves 1.41% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track EIKO LIFESCIENCES LIMITED's announcements?
Every NSE and BSE filing by EIKO LIFESCIENCES LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.